Management Board initiates building approval process for EMA premises in Amsterdam

February 28, 2018 – The European Medicines Agency’s (EMA) Management Board met today in an extraordinary session to further discuss the building approval process for EMA’s future premises in Amsterdam, the Netherlands. EMA needs to be fully operational in Amsterdam on 30 March 2019, when the United Kingdom withdraws from the European Union (EU). At the meeting in Lisbon, Portugal, the Board voted on the revised offer of the Dutch government regarding … (leggi tutto)